Combined iStent infinite, phaco lowers IOP at 2 years

WASHINGTON — At 2 years, trabecular micro-bypass implantation in combination with phacoemulsification yielded IOP reductions in patients with open-angle glaucoma, according to a presenter.
At the American Society of Cataract and Refractive Surgery meeting, Zachary D. Vest, MD, of Mile High Eye Institute, told Healio that the iStent infinite (Glaukos) with phacoemulsification was evaluated in an unmasked, nonrandomized, retrospective, consecutive study in a consistent cohort of 27 eyes that had 24-month data.
{{VIDEO}}
According to Vest, mean IOP decreased from 16 mm Hg at baseline to

Physical activity ups odds of employment among cancer survivors

Cancer survivors may be less likely to be employed as the general population, but meeting HHS physical activity guidelines could significantly increase their odds of employment.
Data presented at American Association for Cancer Research Annual Meeting showed individuals who met aerobic and strength guidelines had a 20% higher likelihood of employment than those who did not.
“Many survivors want to return to work,” Alexis Clouser, MPH, CPH, a PhD student in the department of epidemiology at University of Arkansas for Medical Sciences, told Healio. “This study lays the groundwork for future

Hooked on ID with Lior Cohen-Yatziv, MD

Medicine is full of remarkable specialties, but for me infectious diseases is one of the most intellectually demanding and unpredictable among them, and that’s exactly why I love it.
ID has a way of showing up everywhere. At some point, almost every specialty hits a question that traces back to a bug, a host response or an antibiotic decision. You cannot be a good ID physician without understanding pharmacology, microbiology, immunology and the nuanced physiology of every organ system. Every consult is a lesson in critical thinking.
And just when you think you’ve started to master

FDA expedites review of new HIV treatment combo

The FDA has accepted Gilead Sciences’ new drug application for a single-tablet, once-daily HIV treatment combination and granted the application priority review, according to the drug-maker.
The investigational combination includes two existing Gilead medications: bictegravir (BIC), a guideline-recommended integrase strand transfer inhibitor; and lenacapavir (LEN), a first-in-class capsid inhibitor approved for the treatment of drug-resistant HIV, and also as a long-acting injection for HIV prevention.
Gilead developed the single-tablet regimen for adults who are virologically suppressed

AI app use increased patient understanding of skin conditions

When it comes to identifying skin conditions, AI may increase a patient’s accuracy and confidence, according to a study published in JAMA Dermatology.
Long wait times, limited access to care and financial barriers drive many dermatology patients to seek advice online, Rory Sayres, PhD, a research scientist at Google, and colleagues wrote in the study background. Patients can now upload images of their skin condition to AI programs using their smartphones for more personalized and streamlined medical advice, Sayres said.
“There is a growing multimodal ability with AI. Newer AI models can take

Why blood pressure control starts with weight management

Obesity and hypertension show up together in exam rooms every day.
For many clinicians, the combination feels routine. A patient’s blood pressure creeps up as their weight increases, medications are added or adjusted, and control remains inconsistent.
Over time, both conditions progress, often alongside other chronic conditions such as diabetes and sleep apnea. Despite how common this pattern is, obesity is still frequently treated as a background condition rather than a central driver of elevated blood pressure.
Obesity is one of the strongest modifiable risk factors for hypertension.

Hormonal contraception may increase complications after ACL surgery

NEW ORLEANS — Results presented here showed women on hormonal contraception before ACL surgery were more likely to experience complications and ED visits within 90 days after surgery.
“Patients who are on these types of medications prior to surgery should be counseled on the risk for complications that can be increased after surgery for an ACL injury,” Nicholas Bonazza, MD, associate professor in the department of orthopedic surgery at the University of Arizona, told Healio about results presented at the American Academy of Orthopaedic Surgeons Annual Meeting Specialty Day.
Using the TriNetX

Surgeons discuss toric IOL planning, focusing on incisions

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
This month, we are going to tackle the delicate and somewhat controversial issue of toric IOL planning, with a special focus on incision management. When dealing with astigmatism, nothing is ever easy and straightforward, and this explains the variety of approaches with regard to incision size and location, IOL selection, calculation methods, formulas and tools.
Two experienced specialists, Gary

Pregnancy complications linked to stress, heart risk

Higher levels of psychosocial stress during pregnancy may contribute to risk for future CV events among women who had an adverse pregnancy outcome, researchers reported in Hypertension.
“Women who experience adverse pregnancy outcomes, which includes preeclampsia, gestational hypertension, preterm birth and small for gestational age delivery, have a well-established elevated lifetime risk for cardiovascular disease. The role of modifiable risk factors, specifically psychosocial stress, on cardiovascular risk in women who have had an adverse pregnancy outcome is not well understood,”

GLP-1 microdosing may provide more ‘tailored approach to care’

LAS VEGAS — Prescribing smaller GLP-1 receptor agonist doses could help users tolerate the drugs and lead to a more patient-centered approach to care, but there are also risks health care professionals should be aware of, a speaker stated.
During a presentation at the American Association of Clinical Endocrinology Annual Scientific and Clinical Conference, Anne M. Komé, PharmD, CPP, BCACP, CDCES, clinical pharmacist practitioner in the division of endocrinology and metabolism and department of pharmacy at University of North Carolina at Chapel Hill, discussed the benefits and risks of